Israeli medical centers such as Assuta, Sheba and Ichilov (Sourasky) have multifunctional departments that are well equipped to diagnose and treat various types of cancer. All centers are in possession of modern diagnostics technologies, such as PET-CT, MRI and CT scanners, medical ultrasound, etc. They also have access to groundbreaking tools (such as PET-MRI and 3D mammography) that may not be available elsewhere. Read more
There are three types of skin cancer:
Read more
Thyroid cancers are relatively uncommon. However, with timely treatment, both cure and 10-year survival rates are very high. While experts don’t yet have a definitive answer as to what causes the condition, exposure to radiation (including radiation treatment) is considered a major contributing factor.
Read more
Cervical cancer occurs due to growth of abnormal cervical cells. When found early, it can often be successfully treated. The disease can be diagnosed by means of a PAP-smear.
Read more
Ovarian cancer develops in the ovaries. The tumor’s characteristics will depend on which of the three different types of cells present in the ovaries the type it develops from (epithelial, germ cell or stromal).
When found early, it can often be successfully treated. The disease can be diagnosed by means of a PAP-smear.
Read more
Gallbladder cancer is an extremely rare disease of the digestive tract, more common in women than in men. Its causes include age, family history, gallstones, porcelain gallbladder, choledochal cysts, gallbladder polyps and exposure to certain chemicals (such as nitrosamines). Common symptoms include abdominal pain and bloating, weight loss, jaundice, nausea and fever.
Read more
Most uterine cancers are endometrial, meaning they develop in the lining of the uterus. The disease most commonly develops after menopause. Treatment is most effective when the disease is found at an early stage.
Read more
Breast cancer is the second most common malignancy in US women (after skin cancer). It affects approximately 10-12% of women worldwide. It develops in the cells of the mammary glands and can also, rarely, affect men. When detected early, the disease has a very good prognosis, with a five-year survival rate of over 90%.
Read more
Pages